HBZ

N-{[(4-hydroxyphenyl)carbonyl]carbamoyl}-beta-D-glucopyranosylamine

Created:	2008-02-12
Last modified:	2020-07-17

Find Related PDB Entry
1 entries where HBZ is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	42
Chiral Atom Count	5
Bond Count	43
Aromatic Bond Count	6

2D diagram of HBZ

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	N-{[(4-hydroxyphenyl)carbonyl]carbamoyl}-beta-D-glucopyranosylamine
Synonyms	N-{[(4-hydroxyphenyl)carbonyl]carbamoyl}-beta-D-glucosylamine; N-{[(4-hydroxyphenyl)carbonyl]carbamoyl}-D-glucosylamine; N-{[(4-hydroxyphenyl)carbonyl]carbamoyl}-glucosylamine
Systematic Name (OpenEye OEToolkits)	4-hydroxy-N-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]carbamoyl]benzamide
Formula	C₁₄ H₁₈ N₂ O₈
Molecular Weight	342.301
Type	D-SACCHARIDE

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	10.04	O=C(NC1OC(C(O)C(O)C1O)CO)NC(=O)c2ccc(O)cc2
SMILES	CACTVS	3.341	OC[CH]1O[CH](NC(=O)NC(=O)c2ccc(O)cc2)[CH](O)[CH](O)[CH]1O
SMILES	OpenEye OEToolkits	1.5.0	c1cc(ccc1C(=O)NC(=O)NC2C(C(C(C(O2)CO)O)O)O)O
Canonical SMILES	CACTVS	3.341	OC[C@H]1O[C@@H](NC(=O)NC(=O)c2ccc(O)cc2)[C@H](O)[C@@H](O)[C@@H]1O
Canonical SMILES	OpenEye OEToolkits	1.5.0	c1cc(ccc1C(=O)NC(=O)N[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)O
InChI	InChI	1.03	InChI=1S/C14H18N2O8/c17-5-8-9(19)10(20)11(21)13(24-8)16-14(23)15-12(22)6-1-3-7(18)4-2-6/h1-4,8-11,13,17-21H,5H2,(H2,15,16,22,23)/t8-,9-,10+,11-,13-/m1/s1
InChIKey	InChI	1.03	YHOJJLBUFKEFNL-BZNQNGANSA-N

Related Resource References

Resource Name	Reference
PubChem	24856350
ChEMBL	CHEMBL552199

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.